Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Givastomig in Liver metastases: NCT07432295 Clinical Landscape Report 2026
16 October 2026
NCT07432295 clinical landscape for Liver metastases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Umbilical Cord MSCs therapy(PT. Prodia Stem Cell Indonesia) in Pulmonary Disease, Chronic Obstructive: NCT07441226 Clinical Landscape Report 2026
16 October 2026
NCT07441226 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Amlodipine Besylate in Pulmonary Disease, Chronic Obstructive: NCT07436104 Clinical Landscape Report 2026
16 October 2026
NCT07436104 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
QX-008N in Pulmonary Disease, Chronic Obstructive: NCT07440524 Clinical Landscape Report 2026
16 October 2026
NCT07440524 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Anti-CD3 x anti-HER2 bispecific antibody armed FPBMC(University of Virginia) in Metastatic breast cancer: NCT07441889 Clinical Landscape Report 2026
16 October 2026
NCT07441889 clinical landscape for Metastatic breast cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
161-Terbium PSMA in Metastatic castration-resistant prostate cancer: NCT07441837 Clinical Landscape Report 2026
16 October 2026
NCT07441837 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Zovaglutide in Renal Insufficiency: NCT07443059 Clinical Landscape Report 2026
16 October 2026
NCT07443059 clinical landscape for Renal Insufficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rezvilutamide in Adenocarcinoma of prostate: NCT07444983 Clinical Landscape Report 2026
16 October 2026
NCT07444983 clinical landscape for Adenocarcinoma of prostate: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ropivacaine Hydrochloride in Pain, Postoperative: NCT07452471 Clinical Landscape Report 2026
16 October 2026
NCT07452471 clinical landscape for Pain, Postoperative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
68Ga-FC516 in Prostatic Cancer: NCT07468708 Clinical Landscape Report 2026
16 October 2026
NCT07468708 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Colonic Cancer: NCT07453875 Clinical Landscape Report 2026
16 October 2026
NCT07453875 clinical landscape for Colonic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Risvutatug Rezetecan in Advanced Gastroesophageal Junction Adenocarcinoma: NCT07462923 Clinical Landscape Report 2026
16 October 2026
NCT07462923 clinical landscape for Advanced Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and devel…